Nurse Practitioner, Family · Brooklyn, NY
NPI
1598064743
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8740 25th Ave
Brooklyn, NY, 11214
Phone (718) 891-8790
Groups this clinician bills Medicare through
Medicare paid, 2024
$784K
40,873 services
Medicare patients, 2024
625
Average age 78
Drug cost, 2024
$3.8M
10,502 prescriptions
Company payments, 2025
$1,427
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina Sherman was code 82172 (clinical chemistry), 2,524 times for 545 patients. In total Marina Sherman billed 40,873 services in 82 codes, and Medicare paid $784K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82172 Clinical Chemistry | Office | 2,524 | 545 | $20.67 | $52K |
| 99214 Office E&M - Established | Office | 1,379 | 578 | $99.52 | $137K |
| 84481 Clinical Chemistry | Office | 1,284 | 547 | $16.58 | $21K |
| 85027 Blood Count | Office | 1,284 | 545 | $6.33 | $8,132 |
| 84439 Clinical Chemistry | Office | 1,281 | 547 | $8.83 | $11K |
| 80053 Clinical Chemistry | Office | 1,281 | 546 | $10.34 | $13K |
| 84443 Clinical Chemistry | Office | 1,280 | 547 | $16.44 | $21K |
| 83735 Clinical Chemistry | Office | 1,265 | 546 | $6.56 | $8,302 |
| 84100 Clinical Chemistry | Office | 1,265 | 546 | $4.64 | $5,876 |
| 82248 Clinical Chemistry | Office | 1,265 | 545 | $4.91 | $6,217 |
| 82977 Clinical Chemistry | Office | 1,264 | 545 | $7.05 | $8,914 |
| 83695 Clinical Chemistry | Office | 1,262 | 544 | $14.02 | $18K |
| 80061 Clinical Chemistry | Office | 1,262 | 546 | $13.11 | $17K |
| 84550 Clinical Chemistry | Office | 1,262 | 544 | $4.42 | $5,584 |
| 82728 Clinical Chemistry | Office | 1,177 | 526 | $13.35 | $16K |
By year: 2022 $782K for 40,759 services; 2023 $862K for 41,888 services; 2024 $784K for 40,873 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82172 Clinical Chemistry | 2,524 | 545 | $20.67 | $52K |
| 84481 Clinical Chemistry | 1,284 | 547 | $16.58 | $21K |
| 85027 Blood Count | 1,284 | 545 | $6.33 | $8,132 |
| 80053 Clinical Chemistry | 1,281 | 546 | $10.34 | $13K |
| 84439 Clinical Chemistry | 1,281 | 547 | $8.83 | $11K |
| 84443 Clinical Chemistry | 1,280 | 547 | $16.44 | $21K |
| 82248 Clinical Chemistry | 1,265 | 545 | $4.91 | $6,217 |
| 84100 Clinical Chemistry | 1,265 | 546 | $4.64 | $5,876 |
| 83735 Clinical Chemistry | 1,265 | 546 | $6.56 | $8,302 |
| 82977 Clinical Chemistry | 1,264 | 545 | $7.05 | $8,914 |
Medicare prescription drug claims, 2024
In 2024, the drug Marina Sherman prescribed most often to Medicare patients was Repaglinide, with 745 prescriptions and refills. In total Marina Sherman wrote 10,502 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repaglinide Generic | 745 | 984 | 101 | $12K |
| Levothyroxine Sodium Generic | 559 | 760 | 99 | $3,339 |
| Vascepa Icosapent Ethyl | 519 | 569 | 89 | $186K |
| Rosuvastatin Calcium Generic | 515 | 691 | 109 | $3,691 |
| Ozempic Semaglutide | 447 | 558 | 78 | $491K |
| Acarbose Generic | 430 | 506 | 71 | $5,786 |
| Synthroid Levothyroxine Sodium | 412 | 475 | 56 | $19K |
| Jardiance Empagliflozin | 394 | 504 | 62 | $288K |
| Trulicity Dulaglutide | 360 | 427 | 59 | $399K |
| Atorvastatin Calcium Generic | 323 | 533 | 71 | $2,084 |
| Metformin Hcl Generic | 300 | 479 | 58 | $1,589 |
| Tradjenta Linagliptin | 297 | 349 | 54 | $172K |
| Mounjaro Tirzepatide | 274 | 337 | 51 | $347K |
| Metformin Hcl Er Metformin Hcl | 253 | 377 | 56 | $1,623 |
| Pitavastatin Calcium Generic | 234 | 594 | 71 | $89K |
Brand drugs: 5,176 claims; generic drugs: 4,611 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina Sherman $1,427 ($1,427 in general payments such as food, travel and fees) from 11 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $387.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $387 |
| Amgen Inc. AMGN | 16 | $319 |
| Novo Nordisk Inc NVO | 7 | $145 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $144 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $92.66 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $84.23 |
| Lilly USA, LLC LLY | 4 | $78.86 |
| Recordati_rare_diseases_inc. | 3 | $64.2 |
| Almatica Pharma LLC | 3 | $63.72 |
| Radius Health, Inc. | 1 | $24.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.